0001493152-23-023346.txt : 20230703
0001493152-23-023346.hdr.sgml : 20230703
20230703174600
ACCESSION NUMBER: 0001493152-23-023346
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230701
FILED AS OF DATE: 20230703
DATE AS OF CHANGE: 20230703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KINGSLEY ALFRED D
CENTRAL INDEX KEY: 0001229339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 231066098
MAIL ADDRESS:
STREET 1: 150 E 57TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc.
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTIME INC
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0407
4
2023-07-01
0
0000876343
Lineage Cell Therapeutics, Inc.
LCTX
0001229339
KINGSLEY ALFRED D
C/O LINEAGE CELL THERAPEUTICS
2173 SALK AVENUE, SUITE 200
CARLSBAD
CA
92008
1
1
0
0
Chairman
0
Stock Option (Right to Buy)
1.41
2023-07-01
4
A
0
50000
0.00
A
2033-07-01
Common Shares
50000
50000
D
Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer.
/s/ Alexandra Hernandez, as Attorney-in Fact
2023-07-03